相关实验视频
Updated: Jan 10, 2026
07:48
Engineering a Bilayered Hydrogel to Control ASC Differentiation
Published on: May 25, 2012
14.4K
基于氨酸的混合系统作为生长因子载体,用于治疗慢性伤口
Aneta Ostróżka-Cieślik1, Archana Tanwar2, Monika Michalak3
1Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 41-200 Sosnowiec, Poland.
International journal of molecular sciences
|November 27, 2025
概括
基于氨酸的混合系统与生长因子显示为慢性伤口愈合的承诺. 这些配方促进细胞增殖,迁移和组织再生,加速伤口关闭.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 伤口治愈研究研究 伤口治愈研究
背景情况:
- 慢性伤口治疗带来了重大的临床挑战,往往源于潜在的慢性疾病.
- 氨酸 (HA) 和生长因子 (GF) 是先进伤口护理策略的关键组成部分.
- HA支持纤维细胞活动,而EGF,FGF和VEGF等GF调节细胞过程,对愈合至关重要.
研究的目的:
- 审查混合系统的治疗潜力,将氨酸与生长因子结合起来,用于慢性伤口治疗.
- 总结关于这些先进的伤口护理配方疗效的当前知识.
主要方法:
- 在谷歌学者,科学网和Medline (PubMed) 数据库中进行了系统的文献搜索.
- 本次审查包括18项研究,包括基础研究,临床前研究和临床研究.
- 分析重点是基于HA的混合系统在伤口愈合中的机制和结果.
主要成果:
- 原/HA和酸盐/HA矩阵创造一个潮湿的环境,促进细胞迁移和增殖.
- 皮表皮生长因子 (EGF) 通过刺激角质细胞活动来加速重新上皮化.
- 基本纤维细胞生长因子 (bFGF) 促进血管生成,间接增加VEGF和肝细胞生长因子 (HGF) 形成颗粒组织.
- 含有VEGF的敷料增强了血管化和1型原蛋白的产生.
结论:
- 以生长因子为基础的氨酸混合系统显示了慢性伤口的显著治疗潜力.
- 这些先进的配方促进了关键的愈合过程,包括细胞增殖,迁移,再上皮化和血管生成.
- 需要进一步的临床研究,以充分确定这些有前途的伤口愈合策略的有效性.
相关概念视频
01:23Glycosaminoglycans
6.8K
Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
6.8K
01:19Clinical Applications of Epidermal Stem Cells
3.2K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.2K